(S)-2-(3-{[N-methyl-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)methylamino]-carbonyl}phenylcarbonyl)aminopentanedioic acid

ID: ALA4562619

Chembl Id: CHEMBL4562619

PubChem CID: 137150146

Max Phase: Preclinical

Molecular Formula: C21H22N6O7

Molecular Weight: 470.44

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CN(Cc1cc2c(=O)[nH]c(N)nc2[nH]1)C(=O)c1cccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)c1

Standard InChI:  InChI=1S/C21H22N6O7/c1-27(9-12-8-13-16(23-12)25-21(22)26-18(13)31)19(32)11-4-2-3-10(7-11)17(30)24-14(20(33)34)5-6-15(28)29/h2-4,7-8,14H,5-6,9H2,1H3,(H,24,30)(H,28,29)(H,33,34)(H4,22,23,25,26,31)/t14-/m0/s1

Standard InChI Key:  PNRJTEIZPOHDEE-AWEZNQCLSA-N

Alternative Forms

  1. Parent:

    ALA4562619

    ---

Associated Targets(Human)

SLC19A1 Tchem Folate transporter 1 (134 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FOLR1 Tclin Folate receptor alpha (184 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC46A1 Tchem Proton-coupled folate transporter (236 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 470.44Molecular Weight (Monoisotopic): 470.1550AlogP: 0.15#Rotatable Bonds: 9
Polar Surface Area: 211.57Molecular Species: ACIDHBA: 7HBD: 6
#RO5 Violations: 1HBA (Lipinski): 13HBD (Lipinski): 7#RO5 Violations (Lipinski): 2
CX Acidic pKa: 2.95CX Basic pKa: 4.65CX LogP: -1.71CX LogD: -7.17
Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.25Np Likeness Score: -0.58

References

1. Xiang W, Dekhne A, Doshi A, O'Connor C, Hou Z, Matherly LH, Gangjee A..  (2019)  Discovery of amide-bridged pyrrolo[2,3-d]pyrimidines as tumor targeted classical antifolates with selective uptake by folate receptor α and inhibition of de novo purine nucleotide biosynthesis.,  27  (23): [PMID:31679978] [10.1016/j.bmc.2019.115125]

Source